Cargando…
Glucocorticoid Impaired the Wound Healing Ability of Endothelial Progenitor Cells by Reducing the Expression of CXCR4 in the PGE2 Pathway
Background: Endothelial progenitor cells (EPCs) can be used to treat ischemic disease in cell-based therapy owing to their neovascularization potential. Glucocorticoids (GCs) have been widely used as strong anti-inflammatory reagents. However, despite their beneficial effects, side effects, such as...
Autores principales: | Carolina, Erica, Kato, Toshiki, Khanh, Vuong Cat, Moriguchi, Kana, Yamashita, Toshiharu, Takeuchi, Kosuke, Hamada, Hiromi, Ohneda, Osamu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173212/ https://www.ncbi.nlm.nih.gov/pubmed/30324106 http://dx.doi.org/10.3389/fmed.2018.00276 |
Ejemplares similares
-
Transformed extracellular vesicles with high angiogenic ability as therapeutics of distal ischemic tissues
por: Ngo, Nhat-Hoang, et al.
Publicado: (2022) -
A Chemokine Receptor, CXCR4, Which Is Regulated by Hypoxia-Inducible Factor 2α, Is Crucial for Functional Endothelial Progenitor Cells Migration to Ischemic Tissue and Wound Repair
por: Tu, Tran Cam, et al.
Publicado: (2016) -
Rejuvenation of mesenchymal stem cells by extracellular vesicles inhibits the elevation of reactive oxygen species
por: Khanh, Vuong Cat, et al.
Publicado: (2020) -
SARS-CoV-2 M Protein Facilitates Malignant Transformation of Breast Cancer Cells
por: Nguyen, Hoai-Nga Thi, et al.
Publicado: (2022) -
Wharton's Jelly Mesenchymal Stem Cell-Derived Extracellular Vesicles Reduce SARS-CoV2-Induced Inflammatory Cytokines Under High Glucose and Uremic Toxin Conditions
por: Khanh, Vuong Cat, et al.
Publicado: (2021)